HARBIN, China--(BUSINESS WIRE)--Renhuang Pharmaceuticals, Inc. (or “the Company”, Stock symbol: RHGP.OB), a leading provider of natural health care products in the People’s Republic of China (PRC), today announced a major RMB 19 million (US$ 2.4 million)1 order from Anhui Huayuan Pharmaceutical Co. Ltd, which is one of the oldest and best known pharmaceutical companies in China2
